Not your average joint : Towards precision medicine in psoriatic arthritis

Copyright © 2020. Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 217(2020) vom: 30. Aug., Seite 108470
1. Verfasser: Castillo, Rochelle (VerfasserIn)
Weitere Verfasser: Scher, Jose U
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review Genomics Microbiome Multi-omics Personalized medicine Precision medicine Proteomics Psoriasis Psoriatic arthritis mehr... Seronegative spondyloarthritis Transcriptomics Biomarkers
LEADER 01000naa a22002652 4500
001 NLM310544238
003 DE-627
005 20231225140328.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2020.108470  |2 doi 
028 5 2 |a pubmed24n1035.xml 
035 |a (DE-627)NLM310544238 
035 |a (NLM)32473975 
035 |a (PII)S1521-6616(20)30064-4 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Castillo, Rochelle  |e verfasserin  |4 aut 
245 1 0 |a Not your average joint  |b Towards precision medicine in psoriatic arthritis 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.02.2021 
500 |a Date Revised 01.02.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2020. Published by Elsevier Inc. 
520 |a Precision medicine, propelled by advances in multi-omics methods and analytics, aims to revolutionize patient care by using clinically-actionable molecular markers to guide diagnostic and therapeutic decisions. We describe the applications of precision medicine in risk stratification, drug selection, and treatment response prediction in psoriatic arthritis, for which targeted, personalized approaches are steadily emerging 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a Genomics 
650 4 |a Microbiome 
650 4 |a Multi-omics 
650 4 |a Personalized medicine 
650 4 |a Precision medicine 
650 4 |a Proteomics 
650 4 |a Psoriasis 
650 4 |a Psoriatic arthritis 
650 4 |a Seronegative spondyloarthritis 
650 4 |a Transcriptomics 
650 7 |a Biomarkers  |2 NLM 
700 1 |a Scher, Jose U  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 217(2020) vom: 30. Aug., Seite 108470  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:217  |g year:2020  |g day:30  |g month:08  |g pages:108470 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2020.108470  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 217  |j 2020  |b 30  |c 08  |h 108470